Interaction of metergoline with striatal dopamine system.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000262:Adenylyl Cyclases / Q000378:metabolism; D000284:Administration, Oral; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000096:biosynthesis*; D004873:Ergolines / Q000494:pharmacology*; D006220:Haloperidol / Q000378:metabolism; D007274:Injections, Intraperitoneal; D008711:Metergoline / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors
D004873:Ergolines; D015102:3,4-Dihydroxyphenylacetic Acid; D008711:Metergoline; D000262:Adenylyl Cyclases; D006220:Haloperidol; D004298:Dopamine